Matches in SemOpenAlex for { <https://semopenalex.org/work/W2946985965> ?p ?o ?g. }
- W2946985965 endingPage "365.e1" @default.
- W2946985965 startingPage "356" @default.
- W2946985965 abstract "BackgroundThis analysis compared quality-adjusted time without symptoms of disease progression or toxicity (Q-TWiST) between nivolumab and everolimus among previously treated patients with advanced renal cell carcinoma enrolled in the phase III CheckMate 025 trial (NCT01668784).Materials and MethodsAt 45-month follow-up, overall survival (OS) was partitioned into 3 health states: TWiST, time with grade ≥ 3 toxicity (TOX), and time after progression (REL). Mean Q-TWiST was determined by multiplying each state’s duration with its utility (TWiST, 1.0; TOX, 0.5; REL, 0.5). Relative Q-TWiST gains (calculated as Q-TWiST difference divided by everolimus OS) of ≥ 10% were predefined as clinically important. Immuno-oncology-specific sensitivity analyses considered 4 alternative progression definitions: Tumor size increase ≥ 25% from nadir; treatment discontinuation; ≥ 2-point reduction from baseline in Functional Assessment of Cancer Therapy-Kidney Symptom Index Disease-Related Symptoms scores; and a composite definition. A scenario incorporating grade ≥ 2 toxicities was tested.ResultsCompared with everolimus, nivolumab was associated with a significant Q-TWiST improvement of 3.3 months (P < .001). In all sensitivity analyses, nivolumab was associated with Q-TWiST gains (relative gain %) ranging from 3.3 months (14.4%) to 4.8 months (20.9%).ConclusionsNivolumab is associated with a statistically significant and clinically meaningful gain in quality-adjusted OS versus everolimus among previously treated patients with advanced renal cell carcinoma." @default.
- W2946985965 created "2019-06-07" @default.
- W2946985965 creator A5014188902 @default.
- W2946985965 creator A5039180386 @default.
- W2946985965 creator A5041017512 @default.
- W2946985965 creator A5042331907 @default.
- W2946985965 creator A5059063118 @default.
- W2946985965 creator A5087184017 @default.
- W2946985965 creator A5090387330 @default.
- W2946985965 date "2019-10-01" @default.
- W2946985965 modified "2023-10-17" @default.
- W2946985965 title "A Quality-adjusted Time Without Symptoms or Toxicity (Q-TWiST) Analysis of Nivolumab Versus Everolimus in Advanced Renal Cell Carcinoma (aRCC)" @default.
- W2946985965 cites W1872543517 @default.
- W2946985965 cites W1965664963 @default.
- W2946985965 cites W1976043651 @default.
- W2946985965 cites W1991139838 @default.
- W2946985965 cites W1994361201 @default.
- W2946985965 cites W1995452486 @default.
- W2946985965 cites W2002634103 @default.
- W2946985965 cites W2022007357 @default.
- W2946985965 cites W2033521428 @default.
- W2946985965 cites W2034680734 @default.
- W2946985965 cites W2050302729 @default.
- W2946985965 cites W2077997122 @default.
- W2946985965 cites W2100158834 @default.
- W2946985965 cites W2101571970 @default.
- W2946985965 cites W2102143045 @default.
- W2946985965 cites W2106453307 @default.
- W2946985965 cites W2128229739 @default.
- W2946985965 cites W2136313650 @default.
- W2946985965 cites W2136919572 @default.
- W2946985965 cites W2139192665 @default.
- W2946985965 cites W2159697541 @default.
- W2946985965 cites W2165948908 @default.
- W2946985965 cites W2199766786 @default.
- W2946985965 cites W2222086386 @default.
- W2946985965 cites W2254058470 @default.
- W2946985965 cites W2259708582 @default.
- W2946985965 cites W2290644023 @default.
- W2946985965 cites W2296049142 @default.
- W2946985965 cites W2386935098 @default.
- W2946985965 cites W2414641360 @default.
- W2946985965 cites W2563797543 @default.
- W2946985965 cites W2592028643 @default.
- W2946985965 cites W2592144107 @default.
- W2946985965 cites W2592210846 @default.
- W2946985965 cites W2593338436 @default.
- W2946985965 cites W2597575791 @default.
- W2946985965 cites W2605774324 @default.
- W2946985965 cites W2736166064 @default.
- W2946985965 cites W2765752537 @default.
- W2946985965 cites W2792113799 @default.
- W2946985965 cites W2792333466 @default.
- W2946985965 cites W2889809106 @default.
- W2946985965 cites W4239706257 @default.
- W2946985965 doi "https://doi.org/10.1016/j.clgc.2019.05.010" @default.
- W2946985965 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8262523" @default.
- W2946985965 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31272883" @default.
- W2946985965 hasPublicationYear "2019" @default.
- W2946985965 type Work @default.
- W2946985965 sameAs 2946985965 @default.
- W2946985965 citedByCount "11" @default.
- W2946985965 countsByYear W29469859652020 @default.
- W2946985965 countsByYear W29469859652021 @default.
- W2946985965 countsByYear W29469859652022 @default.
- W2946985965 crossrefType "journal-article" @default.
- W2946985965 hasAuthorship W2946985965A5014188902 @default.
- W2946985965 hasAuthorship W2946985965A5039180386 @default.
- W2946985965 hasAuthorship W2946985965A5041017512 @default.
- W2946985965 hasAuthorship W2946985965A5042331907 @default.
- W2946985965 hasAuthorship W2946985965A5059063118 @default.
- W2946985965 hasAuthorship W2946985965A5087184017 @default.
- W2946985965 hasAuthorship W2946985965A5090387330 @default.
- W2946985965 hasBestOaLocation W29469859651 @default.
- W2946985965 hasConcept C121608353 @default.
- W2946985965 hasConcept C126322002 @default.
- W2946985965 hasConcept C126894567 @default.
- W2946985965 hasConcept C141071460 @default.
- W2946985965 hasConcept C143998085 @default.
- W2946985965 hasConcept C2524010 @default.
- W2946985965 hasConcept C2776196297 @default.
- W2946985965 hasConcept C2777472916 @default.
- W2946985965 hasConcept C2777701055 @default.
- W2946985965 hasConcept C2778715236 @default.
- W2946985965 hasConcept C2779699572 @default.
- W2946985965 hasConcept C2780030458 @default.
- W2946985965 hasConcept C2781068499 @default.
- W2946985965 hasConcept C29730261 @default.
- W2946985965 hasConcept C33923547 @default.
- W2946985965 hasConcept C71924100 @default.
- W2946985965 hasConceptScore W2946985965C121608353 @default.
- W2946985965 hasConceptScore W2946985965C126322002 @default.
- W2946985965 hasConceptScore W2946985965C126894567 @default.
- W2946985965 hasConceptScore W2946985965C141071460 @default.
- W2946985965 hasConceptScore W2946985965C143998085 @default.
- W2946985965 hasConceptScore W2946985965C2524010 @default.
- W2946985965 hasConceptScore W2946985965C2776196297 @default.
- W2946985965 hasConceptScore W2946985965C2777472916 @default.